Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 2, 2010, Pages 740-747

  Laughlin, Gail A ^a   Goodell, Vivian ^a   Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; OBESITY; OUTCOME ASSESSMENT; OVARY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TESTOSTERONE BLOOD LEVEL;

EID: 76149108405     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1693     Document Type: Article

References (40)

1. Liu Y, Ding J, Bush TL, Longenecker JC, Nieto FJ, Golden SH, Szklo M 2001 Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. Am J Epidemiol 154:489 -494
2. Cussons AJ, Stuckey BG, Watts GF 2006 Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis 185:227-239
3. Wild S, Pierpoint T, McKeigue P, Jacobs H 2000 Cardiovascular disease inwomenwith polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 52:595-600
4. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS 1998 Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51:581-586
5. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ 2008 Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 93:1276-1284
6. Khatibi A, Agardh CD, Shakir YA, Nerbrand C, Nyberg P, Lidfeldt J, Samsioe G 2007 Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: The Women's Health in the Lund Area (WHILA) Study. Climacteric 10:386-392
7. Bernini GP, Sgro' M, Moretti A, Argenio GF, Barlascini CO, Cristofani R, Salvetti A 1999 Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 84: 2008-2012
8. Golden SH, Maguire A, Ding J, Crouse JR, Cauley JA, Zacur H, Szklo M 2002 Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am J Epidemiol 155:437-445
9. Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A 2007 Role of endogenous androgens on carotid atherosclerosis in non-obese postmenopausal women. Nutr Metab Cardiovasc Dis 17:705-711
10. Kaczmarek A, Reczuch K, Majda J, Banasiak W, Ponikowski P 2003 The association of lower testosterone level with coronary artery disease in postmenopausal women. Int J Cardiol 87:53-57
11. Khosla S 2006 Editorial: sex hormone binding globulin: inhibitor or facilitator (or both) of sex steroid action? J Clin Endocrinol Metab 91:4764-4766
12. Crave JC, Lejeune H, Brébant C, Baret C, Pugeat M 1995 Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells. J Clin Endocrinol Metab 80:1283-1289
13. Laughlin GA, Barrett-Connor E, May S 2007 Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Int J Obes (Lond) 31:457-465
14. 1976 The hypertension detection and follow-up program: hypertension detection and follow-up program cooperative group. Prev Med 5:207-215
15. Rosner W 1972 A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity in human plasma. J Clin Endocrinol Metab 34:983-988
16. Tremblay RR, Dube JY 1974 Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 10:599-605
17. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18:499-502
18. 1999 Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization
19. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 2002 Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421
20. May S, Hosmer DW 1998 A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model. Lifetime Data Anal 4:109-120
21. Reinecke H, Bogdanski J, Woltering A, Breithardt G, Assmann G, Kerber S, von Eckardstein A 2002 Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women. Am J Cardiol 90:364-368
22. Weinberg ME, Manson JE, Buring JE, Cook NR, Seely EW, Ridker PM, Rexrode KM 2006 Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism 55:1473-1480
23. Bell RJ, Davison SL, Papalia MA, McKenzie DP, Davis SR 2007 Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause 14:630-638
24. Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI 2003 Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/ Progestin Intervention Trial. J Clin Endocrinol Metab 88:1646-1652
25. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL 2002 Endogenous sexhormonesandthe development of type2diabetes in oldermen and women: the Rancho Bernardo study. Diabetes Care 25:55-60
26. Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, Pasternak RC, Lloyd-Jones D, Sowers MF, Torréns JI 2005 Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 111:1242-1249
27. Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M, Golden SH 2005 Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab 90:1202-1209
28. Ding EL, Song Y, Malik VS, Liu S 2006 Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295:1288-1299
29. Golden SH, Ding J, Szklo M, Schmidt MI, Duncan BB, Dobs A 2004 Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol 160:540-548
30. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Paolisso G, Ble A, Egan JM, Metter EJ, Abbatecola AM, Zuliani G, Ruggiero C, Valenti G, Guralnik JM, Ferrucci L 2007 Association of hormonal dysregulation with metabolic syndrome in older women: data from the In CHIANTI study. Am J Physiol Endocrinol Metab 292: E353-E358
31. Ouyang P, Vaidya D, Dobs A, Golden SH, Szklo M, Heckbert SR, Kopp P, Gapstur SM 2009 Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 204:255-261
32. Debing E, Peeters E, Duquet W, Poppe K, Velkeniers B, Van den Brande P 2007 Endogenous sex hormone levels in postmenopausal womenundergoing carotid artery endarterectomy. Eur J Endocrinol 156:687-693
33. Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, Pols HA 2002 Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 87:3632-3639
34. Nettleship JE, Jones RD, Channer KS, Jones TH 2009 Testosterone and coronary artery disease. Front Horm Res 37:91-107
35. Rexrode KM, Manson JE, Lee IM, Ridker PM, Sluss PM, Cook NR, Buring JE 2003 Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 108:1688-1693
36. Stanczyk FZ, Cho MM, Endres DB, Morrison JL, Patel S, Paulson RJ 2003 Limitations of direct estradiol and testosterone immunoassay kits. Steroids 68:1173-1178
37. Ng MK, Liu PY, Williams AJ, Nakhla S, Ly LP, Handelsman DJ, Celermajer DS 2002 Prospective study of effect of androgens on serum inflammatory markers in men. Arterioscler Thromb Vasc Biol 22:1136-1141
38. Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A 2007 Endogenous testosterone and endothelial function in post-menopausal women. Coron Artery Dis 18:9-13
39. Malkin CJ, Pugh PJ, Jones RD, Jones TH, Channer KS 2003 Testosterone as a protective factor against atherosclerosis - immunomodulation and influence upon plaque development and stability. J Endocrinol 178:373-380
40. Hankinson SE, Manson JE, Spiegelman D, Willett WC,Longcope C, Speizer FE 1995 Reproducibility of plasma hormone levels in post-menopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 4:649-654